Your browser doesn't support javascript.
loading
Ertapenem-induced encephalopathy in a patient with liver abscess and acute kidney injury.
Farooq, Shahid; Acosta, Allan.
Afiliación
  • Farooq S; Acute and General Medicine, Causeway Hospital, Coleraine, UK shahid.farooq@northerntrust.hscni.net.
  • Acosta A; Acute and General Medicine, Causeway Hospital, Coleraine, UK.
BMJ Case Rep ; 17(1)2024 Jan 03.
Article en En | MEDLINE | ID: mdl-38171638
ABSTRACT
A man in his late 70s, retired and independent, generally fit and well with a history of normal cognitive function baseline presented with liver abscess and acute kidney injury. He received meropenem 1 g three times a day for 15 days then subsequently changed to ertapenem 1 g one time a day in preparation for outpatient antibiotic treatment. After 2 days of starting ertapenem, the patient developed night-time delirium, decreased orientation and insomnia, loss of appetite, jerking and hallucination. Investigations have been done to investigate the cause of acute delirium, including lumbar puncture, CT brain, MRI brain, repeat CT abdomen and pelvis to monitor the liver abscess, and electroencephalogram but results were all unremarkable. Medication history during admission was reviewed and discontinued one by one the medications that were suspected to have caused the encephalopathy. Two days following the discontinuation of ertapenem, the patient's symptoms improved with a rapid return to his baseline and without neurological deficit.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encefalopatías / Delirio / Lesión Renal Aguda / Absceso Hepático Límite: Humans / Male Idioma: En Revista: BMJ Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encefalopatías / Delirio / Lesión Renal Aguda / Absceso Hepático Límite: Humans / Male Idioma: En Revista: BMJ Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido
...